By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...

The trading gives Waltham-based Kailera a market value of almost $3.1 billion based on the outstanding shares listed in its ...

Guidance from three obesity associations offers recommendations for specific obesity medications and spells out the need to reduce stigma. Will it help?

Obesity is linked to increased cancer risk through inflammation, metabolic dysfunction, and immune changes. Dr. Jennifer ...

The Senate Health and Welfare Committee debated a bill that would require Medicaid to cover FDA-approved weight-loss ...

Adolescents who consume more ultra-processed foods (UPFs) have significantly higher odds of being overweight or obese, ...

Louisiana lawmakers debated a bill that would require Medicaid to cover FDA-approved weight-loss medications for its ...

Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity ...

In an approval letter for Foundayo, the FDA said Lilly was required to submit data from the trial by July in order to ...

India is an important market for Lilly and we are committed to making orforglipron available to patients globally, including ...

Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...

Hedonic eating as a key driver of overeating and obesity. Doctors explain the complexities of obesity and its association ...